US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 5.340
  • -0.410-7.13%
Close Mar 28 16:00 ET
  • 5.430
  • +0.090+1.69%
Post 19:22 ET
238.58MMarket Cap-5741P/E (TTM)

Cardiff Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
-55.66%-6.7M
-74.18%-10.25M
Net income from continuing operations
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
-54.55%-10.44M
-112.26%-10.99M
Operating gains losses
----
----
----
----
----
100.35%1K
----
----
----
----
Depreciation and amortization
68.64%398K
19.77%103K
32.10%107K
157.89%98K
190.32%90K
-47.67%236K
-23.89%86K
-26.36%81K
-65.14%38K
-73.95%31K
Other non cash items
----
----
----
----
----
-93.16%139K
--0
--0
--0
-63.42%139K
Change In working capital
1,828.42%6.57M
179.39%1.39M
791.22%1.02M
5.61%2.58M
270.24%1.57M
78.76%-380K
-8,660.00%-1.75M
76.55%-148K
636.14%2.44M
37.14%-924K
-Change in receivables
304.66%483K
25.62%-90K
62.63%-37K
595.19%515K
7.95%95K
-9.77%-236K
14.18%-121K
-15.12%-99K
-55.22%-104K
11.39%88K
-Change in prepaid assets
815.35%3.17M
95.75%-19K
6,728.57%928K
-12.94%1.01M
209.64%1.25M
78.89%-443K
67.08%-447K
98.27%-14K
361.75%1.16M
-523.50%-1.14M
-Change in payables and accrued expense
110.01%2.83M
6,000.00%1.4M
421.43%135K
-20.26%1.09M
--203K
87.48%1.35M
-98.52%23K
-114.43%-42K
355.67%1.37M
--0
-Change in other current assets
207.96%651K
122.80%243K
0.73%138K
-22.30%108K
-13.37%162K
-178.01%-603K
-946.03%-1.07M
-59.82%137K
139.66%139K
-24.60%187K
-Change in other current liabilities
-26.91%-566K
-3.55%-146K
-8.46%-141K
-20.51%-141K
-137.93%-138K
53.88%-446K
28.06%-141K
64.67%-130K
44.29%-117K
69.95%-58K
Cash from discontinued investing activities
Operating cash flow
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
-55.66%-6.7M
-74.18%-10.25M
Investing cash flow
Cash flow from continuing investing activities
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
140.03%7.61M
116.44%18.36M
Capital expenditure reported
42.15%-582K
89.33%-8K
29.69%-315K
19.55%-251K
95.32%-8K
-390.73%-1.01M
29.91%-75K
-357.14%-448K
---312K
---171K
Net investment purchase and sale
-5.80%36.78M
91.25%13.57M
-25.72%4.14M
49.51%11.74M
-60.40%7.34M
129.75%39.04M
181.67%7.1M
-31.66%5.57M
141.30%7.85M
116.59%18.53M
Net other investing changes
----
----
----
----
----
--114K
--0
--43K
----
----
Cash from discontinued investing activities
Investing cash flow
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
140.03%7.61M
116.44%18.36M
Financing cash flow
Cash flow from continuing financing activities
0
0
-99.79%75K
0
Proceeds from stock option exercised by employees
--0
--0
----
----
----
-94.06%75K
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
--0
--0
-99.79%75K
--0
--75K
--0
--0
Net cash flow
Beginning cash position
36.88%16.35M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
-90.88%11.94M
42.17%18.72M
98.14%20.97M
36.76%20.05M
-90.88%11.94M
Current changes in cash
20.53%5.31M
370.97%6.42M
-83.99%-4.14M
376.67%4.35M
-116.40%-1.33M
103.70%4.4M
-93.94%-2.37M
-187.00%-2.25M
122.37%913K
106.97%8.11M
End cash Position
32.47%21.66M
32.47%21.66M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
36.88%16.35M
42.17%18.72M
98.14%20.97M
36.76%20.05M
Free cash flow
9.64%-31.47M
24.49%-7.15M
-4.26%-8.27M
-5.37%-7.38M
16.82%-8.67M
-49.82%-34.83M
-26.25%-9.47M
-42.62%-7.93M
-62.92%-7.01M
-77.09%-10.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M-55.66%-6.7M-74.18%-10.25M
Net income from continuing operations -7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M-54.55%-10.44M-112.26%-10.99M
Operating gains losses --------------------100.35%1K----------------
Depreciation and amortization 68.64%398K19.77%103K32.10%107K157.89%98K190.32%90K-47.67%236K-23.89%86K-26.36%81K-65.14%38K-73.95%31K
Other non cash items ---------------------93.16%139K--0--0--0-63.42%139K
Change In working capital 1,828.42%6.57M179.39%1.39M791.22%1.02M5.61%2.58M270.24%1.57M78.76%-380K-8,660.00%-1.75M76.55%-148K636.14%2.44M37.14%-924K
-Change in receivables 304.66%483K25.62%-90K62.63%-37K595.19%515K7.95%95K-9.77%-236K14.18%-121K-15.12%-99K-55.22%-104K11.39%88K
-Change in prepaid assets 815.35%3.17M95.75%-19K6,728.57%928K-12.94%1.01M209.64%1.25M78.89%-443K67.08%-447K98.27%-14K361.75%1.16M-523.50%-1.14M
-Change in payables and accrued expense 110.01%2.83M6,000.00%1.4M421.43%135K-20.26%1.09M--203K87.48%1.35M-98.52%23K-114.43%-42K355.67%1.37M--0
-Change in other current assets 207.96%651K122.80%243K0.73%138K-22.30%108K-13.37%162K-178.01%-603K-946.03%-1.07M-59.82%137K139.66%139K-24.60%187K
-Change in other current liabilities -26.91%-566K-3.55%-146K-8.46%-141K-20.51%-141K-137.93%-138K53.88%-446K28.06%-141K64.67%-130K44.29%-117K69.95%-58K
Cash from discontinued investing activities
Operating cash flow 8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M-55.66%-6.7M-74.18%-10.25M
Investing cash flow
Cash flow from continuing investing activities -5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M140.03%7.61M116.44%18.36M
Capital expenditure reported 42.15%-582K89.33%-8K29.69%-315K19.55%-251K95.32%-8K-390.73%-1.01M29.91%-75K-357.14%-448K---312K---171K
Net investment purchase and sale -5.80%36.78M91.25%13.57M-25.72%4.14M49.51%11.74M-60.40%7.34M129.75%39.04M181.67%7.1M-31.66%5.57M141.30%7.85M116.59%18.53M
Net other investing changes ----------------------114K--0--43K--------
Cash from discontinued investing activities
Investing cash flow -5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M140.03%7.61M116.44%18.36M
Financing cash flow
Cash flow from continuing financing activities 00-99.79%75K0
Proceeds from stock option exercised by employees --0--0-------------94.06%75K--0------------
Cash from discontinued financing activities
Financing cash flow --0--0--0--0--0-99.79%75K--0--75K--0--0
Net cash flow
Beginning cash position 36.88%16.35M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M-90.88%11.94M42.17%18.72M98.14%20.97M36.76%20.05M-90.88%11.94M
Current changes in cash 20.53%5.31M370.97%6.42M-83.99%-4.14M376.67%4.35M-116.40%-1.33M103.70%4.4M-93.94%-2.37M-187.00%-2.25M122.37%913K106.97%8.11M
End cash Position 32.47%21.66M32.47%21.66M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M36.88%16.35M42.17%18.72M98.14%20.97M36.76%20.05M
Free cash flow 9.64%-31.47M24.49%-7.15M-4.26%-8.27M-5.37%-7.38M16.82%-8.67M-49.82%-34.83M-26.25%-9.47M-42.62%-7.93M-62.92%-7.01M-77.09%-10.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg